IP Library Assignment 071840/0471
Patent Assignment
Reel/Frame 071840/0471

Assignment of Assignor's Interest

Recorded: 2025-07-07 Pages: 23
Assignor
REGENXBIO INC.
Executed: 2025-06-27
Assignee
REGENXBIO RS LLC
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MARYLAND, 20850
Covered Properties (30)
Adeno-Associated Virus Mediated Gene Transfer to the Central Nervous System
Application: 61/823,757 →
Methods to Treat Mucopolysaccharide Type I or Deficiency in Alpha-L-Iduronidase Using a Recombinant Adeno-Associated Virus Encoding Alpha-L-Iduronidase
Patent: 9,827,295 →
Application: 14/889,750 →
Publication: US 2016/0120960
Adeno-Associated Virus Mediated Gene Transfer to the Central Nervous System
Application: 15/717,450 →
Publication: US 2018/0036388
Adeno-Associated Virus Mediated Gene Transfer to the Central Nervous System
Application: 15/987,490 →
Publication: US 2018/0264090
Adeno-Associated Virus Mediated Gene Transfer to the Central Nervous System
Application: 15/989,405 →
Publication: US 2018/0271955
Methods to Treat Pompe Disease Using a Recombinant Adeno-Associated Virus
Application: 17/118,353 →
Publication: US 2021/0085759
Adeno-Associated Virus Mediated Gene Transfer to the Central Nervous System
Application: 17/118,395 →
Publication: US 2021/0085760
Adeno-Associated Virus Mediated Gene Transfer to the Central Nervous System
Application: 17/212,516 →
Publication: US 2021/0346473
Methods to Treat Mucopolysaccharidosis Type Ii or Deficiency in Iduronate-2-Sulfatase Using a Recombinant Adeno-Associated Virus (Aav) Vector Encoding Iduronate-2-Sulfatase
Application: 15/717,358 →
Publication: US 2018/0099030
Methods to Treat Pompe Disease Using a Recombinant Adeno-Associated Virus
Application: 15/995,045 →
Publication: US 2018/0271956
Methods to Treat Ceroid Lipofuscinosis Using a Recombinant Adeno-Associated Virus
Application: 15/995,055 →
Publication: US 2018/0271957
Adeno-Associated Virus Mediated Gene Transfer to the Central Nervous System
Application: 16/438,143 →
Publication: US 2019/0298812
Intranasal Delivery of Adeno-Associated for Therapeutic Delivery to Central Nervous System
Application: 62/162,174 →
Intranasal Delivery of Adeno-Associated for Therapeutic Delivery to Central Nervous System
Application: 62/252,055 →
Intranasal Delivery of Adeno-Associated for Therapeutic Delivery to Central Nervous System
Application: 62/301,980 →
Intranasal Delivery of Adeno-Associated for Therapeutic Delivery to Central Nervous System
Application: 62/331,156 →
Intranasal Administration of Adeno-Associated Virus to Treat Central Nervous System Disorders
Application: 15/574,432 →
Publication: US 2018/0289839
Adeno-Associated Virus for Therapeutic Delivery to Central Nervous System
Application: 17/344,308 →
Publication: US 2021/0369871
Intranasal Administration of Adeno-Associated Virus to Treat Central Nervous System Disorders
Application: 17/574,118 →
Publication: US 2022/0211875
Adeno-Associated Virus for Therapeutic Delivery to Central Nervous System
Application: 15/813,908 →
Publication: US 2018/0071373
Adeno-Associated Virus for Therapeutic Delivery to Central Nervous System
Application: 18/150,740 →
Publication: US 2023/0226225
Method for Recovery of Neurological Function in Mps Ii
Application: 62/422,436 →
Method for Recovery of Neurological Function in Mps Ii
Application: 62/458,248 →
Method for Improving Neurological Function in Mpsi and Mpsii and Other Neurological Disorders
Application: 16/461,271 →
Publication: US 2019/0269799
Method for Improving Neurological Function in Mpsi and Mpsii and Other Neurological Disorders
Application: 17/508,714 →
Publication: US 2022/0096659
Methods for Preventing Cardiac or Skeletal Defects in Diseases Including Mucopolysaccharidoses
Application: 63/146,383 →
Methods for Preventing Cardiac or Skeletal Defects in Diseases Including Mucopolysaccharidoses
Application: 63/185,743 →
Methods for Preventing Cardiac or Skeletal Defects in Diseases Including Mucopolysaccharidoses
Application: 63/186,491 →
Methods for Preventing Cardiac or Skeletal Defects in Diseases Including Mucopolysaccharidoses
Application: 63/283,920 →
Methods for Preventing Cardiac or Skeletal Defects in Diseases Including Mucopolysaccharidoses
Application: 18/264,364 →
Publication: US 2024/0316217
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 24, 2015
From: KOZARSKY, KAREN
To: REGENXBIO INC.
Reel/Frame 035895/0694 →
Assignment of Assignor's Interest Jun 29, 2015
From: KOZARSKY, KAREN
To: REGENXBIO INC.
Reel/Frame 035926/0236 →
Assignment of Assignor's Interest Jun 29, 2015
From: MCIVOR, R. SCOTT; BELUR, LALITHA R.; LOW, WALTER; FAIRBANKS, CAROLYN
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 035956/0928 →
Assignment of Assignor's Interest Jul 14, 2015
From: KOZARSKY, KAREN
To: REGENXBIO INC.
Reel/Frame 036077/0699 →
Assignment of Assignor's Interest Jul 27, 2015
From: MCIVOR, R. SCOTT; BELUR, LALITHA R.
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 036184/0741 →
Confirmatory License Dec 7, 2015
From: UNIVERSITY OF MINNESOTA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 037226/0098 →
Assignment of Assignor's Interest Jan 7, 2016
From: KOZARSKY, KAREN
To: REGENXBIO INC.
Reel/Frame 037426/0642 →
Assignment of Assignor's Interest Feb 23, 2016
From: BELUR, LALITHA R.
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 037800/0356 →
Assignment of Assignor's Interest Mar 9, 2016
From: MCIVOR, R. SCOTT
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 037933/0765 →
Assignment of Assignor's Interest Apr 26, 2016
From: MCIVOR, R. SCOTT; BELUR, LALITHA R.; FAIRBANKS, CAROLYN
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 038377/0772 →
Assignment of Assignor's Interest Apr 26, 2016
From: MCIVOR, R. SCOTT; BELUR, LALITHA R.
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 038377/0809 →
Assignment of Assignor's Interest May 13, 2016
From: KOZARSKY, KAREN
To: REGENXBIO INC.
Reel/Frame 038593/0037 →
Assignment of Assignor's Interest May 13, 2016
From: KOZARSKY, KAREN
To: REGENXBIO INC.
Reel/Frame 038593/0132 →
Assignment of Assignor's Interest Sep 26, 2017
From: KOZARSKY, KAREN, PH.D
To: REGENXBIO INC.
Reel/Frame 043704/0411 →
Assignment of Assignor's Interest Sep 26, 2017
From: LOW, WALTER
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 043704/0216 →
Confirmatory License Oct 24, 2017
From: UNIVERSITY OF MINNESOTA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044279/0968 →
Confirmatory License Nov 2, 2017
From: UNIVERSITY OF MINNESOTA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044351/0408 →
Assignment of Assignor's Interest Dec 15, 2017
From: KOZARSKY, KAREN, PH.D
To: REGENXBIO INC.
Reel/Frame 044405/0435 →
Assignment of Assignor's Interest Dec 15, 2017
From: MCIVOR, R. SCOTT; BELUR, LALITHA R.; LOW, WALTER; FAIRBANKS, CAROLYN
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 044405/0603 →
Confirmatory License Dec 18, 2017
From: UNIVERSITY OF MINNESOTA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044888/0898 →
Confirmatory License Dec 18, 2017
From: UNIVERSITY OF MINNESOTA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 044888/0900 →
Assignment of Assignor's Interest Jan 18, 2018
From: MCIVOR, R. SCOTT; BELUR, LALITHA R.
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 044648/0406 →
Assignment of Assignor's Interest Jan 29, 2018
From: LAOHARAWEE, KANUT; PODETZ-PEDERSEN, KELLY M.; MCIVOR, R. SCOTT
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 044750/0771 →
Assignment of Assignor's Interest Jan 30, 2018
From: KOZARSKY, KAREN, PH.D
To: REGENXBIO INC.
Reel/Frame 044766/0975 →
Assignment of Assignor's Interest Feb 2, 2018
From: LAOHARAWEE, KANUT; PODETZ-PEDERSEN, KELLY M.; MCIVOR, R. SCOTT
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 044811/0018 →